P2‐045: THE MODEL‐AD CONSORTIUM PRECLINICAL TESTING PIPELINE: PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPHYLACTIC TREATMENT WITH LEVETIRACETAM IN THE 5XFAD MOUSE MODEL OF ALZHEIMER'S DISEASE
| Autor: | Jill A. Meyer, Amanda A. Riley, Kelly J. Keezer, Paul R. Territo, Michael Sasner, Brian P. McCarthy, Sara K. Quinney, Harriett Williams, Gareth R. Howell, Jonathan S. Peters, Bruce T. Lamb, Kristen D. Onos, David R. Jones, Stacey J. Sukoff Rizzo, Andrea R. Masters, Ingrid F. Metzger, Scott C. Persohn, Adrian L. Oblak |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Oncology
medicine.medical_specialty Epidemiology business.industry Health Policy Pipeline (computing) Disease Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Pharmacokinetics Preclinical testing Internal medicine medicine Neurology (clinical) Levetiracetam Geriatrics and Gerontology business medicine.drug Prophylactic treatment |
| Zdroj: | Alzheimer's & Dementia. 14 |
| ISSN: | 1552-5279 1552-5260 |
| DOI: | 10.1016/j.jalz.2018.06.729 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|